| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.7 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |